Evidence map›Paper›PMID 25809253›Full record

ArticleBiophysical journal2015

NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation.

Jiqing Guo, Yen May Cheng, James P Lees-Miller, Laura L Perissinotti, Tom W Claydon, Christina M Hull, Samrat Thouta, Daniel E Roach, Serdar Durdagi, Sergei Y Noskov and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Molecular Determinants of Voltage-Dependent Gating in Kv11.1 Channels.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Modulation of hERG KFrontiers in pharmacology · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jiqing GuoLibin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
Yen May ChengDepartment of Biomedical Physiology and Kinesiology, Molecular Cardiac Physiology Group, Simon Fraser University, Burnaby, British Columbia, Canada.
James P Lees-MillerLibin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
Laura L PerissinottiCentre for Molecular Simulations, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
Tom W ClaydonDepartment of Biomedical Physiology and Kinesiology, Molecular Cardiac Physiology Group, Simon Fraser University, Burnaby, British Columbia, Canada.
Christina M HullDepartment of Biomedical Physiology and Kinesiology, Molecular Cardiac Physiology Group, Simon Fraser University, Burnaby, British Columbia, Canada.
Samrat ThoutaDepartment of Biomedical Physiology and Kinesiology, Molecular Cardiac Physiology Group, Simon Fraser University, Burnaby, British Columbia, Canada.
Daniel E RoachLibin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
Serdar DurdagiCentre for Molecular Simulations, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.
Sergei Y NoskovLibin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada; Centre for Molecular Simulations, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address: snoskov@ucalgary.ca.
Henry J DuffLibin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada. Electronic address: hduff@ucalgary.ca.
University of Calgary · CASimon Fraser University · CALibin Cardiovascular Institute of Alberta · CA

Funding

Canadian Institutes of Health Research MOP-186232
6 · The paper itself

Abstract

Activators of hERG1 such as NS1643 are being developed for congenital/acquired long QT syndrome. Previous studies identify the neighborhood of L529 around the voltage-sensor as a putative interacting site for NS1643. With NS1643, the V1/2 of activation of L529I (-34 ± 4 mV) is similar to wild-type (WT) (-37 ± 3 mV; P > 0.05). WT and L529I showed no difference in the slope factor in the absence of NS1643 (8 ± 0 vs. 9 ± 0) but showed a difference in the presence of NS1643 (9 ± 0.3 vs. 22 ± 1; P < 0.01). Voltage-clamp-fluorimetry studies also indicated that in L529I, NS1643 reduces the voltage-sensitivity of S4 movement. To further assess mechanism of NS1643 action, mutations were made in this neighborhood. NS1643 shifts the V1/2 of activation of both K525C and K525C/L529I to hyperpolarized potentials (-131 ± 4 mV for K525C and -120 ± 21 mV for K525C/L529I). Both K525C and K525C/K529I had similar slope factors in the absence of NS1643 (18 ± 2 vs. 34 ± 5, respectively) but with NS1643, the slope factor of K525C/L529I increased from 34 ± 5 to 71 ± 10 (P < 0.01) whereas for K525C the slope factor did not change (18 ± 2 at baseline and 16 ± 2 for NS1643). At baseline, K525R had a slope factor similar to WT (9 vs. 8) but in the presence of NS1643, the slope factor of K525R was increased to 24 ± 4 vs. 9 ± 0 mV for WT (P < 0.01). Molecular modeling indicates that L529I induces a kink in the S4 voltage-sensor helix, altering a salt-bridge involving K525. Moreover, docking studies indicate that NS1643 binds to the kinked structure induced by the mutation with a higher affinity. Combining biophysical, computational, and electrophysiological evidence, a mechanistic principle governing the action of some activators of hERG1 channels is proposed.

Indexed as

AnimalsBinding SitesCell LineCresolsERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsFluorometryHumansMembrane PotentialsMolecular Docking SimulationMolecular Dynamics SimulationMutationOocytesPatch-Clamp TechniquesPhenylurea CompoundsProtein Structure, Secondary1,3-bis(2-hydroxy-5-trifluoromethylphenyl)ureaCresolsERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsKCNH2 protein, humanPhenylurea Compounds

Identifiers

PMID25809253
PMCPMC4375528
OpenAlexW2137453413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.